Parameter | Estimate | SE | Pvalue |
---|
Intercept | 3.32 | 0.32 | < 0.0001 |
DECTIN-1 genotype | 0.05 | 0.79 |
0.95
|
Intercept | 1.07 | 0.58 | 0.065 |
DECTIN-1 genotype | -0.40 | 0.71 |
0.57
|
Joint damage at baseline | 2.65 | 0.53 | < 0.0001 |
Rheumatoid factor + | 1.28 | 0.63 | 0.043 |
Average DAS28a | 1.26 | 0.24 | < 0.0001 |
- DAS28: Disease Activity Score using 28 joint counts. Results of the linear regression model with 262 RA patients. The upper model tests the difference in annual joint-damage progression rate between wild-type patients and patients heterozygous for the DECTIN-1 Y238X polymorphism, indicated by the estimate of DECTIN-1 genotype (P = 0.95). The lower model tests the same (P = 0.57), with addition of baseline joint damage, rheumatoid factor positivity, and the time-averaged DAS28 as confounders. aTime-averaged DAS28 was centered.